Description
DASL RAPIDTM, a molecular diagnostic assay platform, will be used to develop a rapid test for SARS-CoV-2 in fluids collected from throat and nasal swabs. The prototype will be transferable for scale-up in public health laboratories or point…
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $307,764 at start, $307,764 after amendment #2 (+$0).
- #12020-04-22$307,764
- #12020-04-22$307,764
- #22021-02-11$307,764
- #22021-02-11$307,764
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-04-22 | $307,764 | — | DASL RAPIDTM, a molecular diagnostic assay platform, will be used to develop a rapid test for SARS-CoV-2 in fl… |
| #1 amendment | 2020-04-22 | $307,764 | +$0 | DASL RAPIDTM, a molecular diagnostic assay platform, will be used to develop a rapid test for SARS-CoV-2 in fl… |
| #2 amendment | 2021-02-11 | $307,764 | +$0 | DASL RAPIDTM, a molecular diagnostic assay platform, will be used to develop a rapid test for SARS-CoV-2 in fl… |
| #2 amendment | 2021-02-11 | $307,764 | +$0 | DASL RAPIDTM, a molecular diagnostic assay platform, will be used to develop a rapid test for SARS-CoV-2 in fl… |
Related records · 10
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 867782351)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2022-2023-Q4-1001057 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program | $30,000 | FY2023 |
| 172-2021-2022-Q1-973206 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $50,000 | FY2022 |
| 062-2020-2021-Q2-00026 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Regional Relief and Recovery Fund (RRRF) – For Profit | $214,022 | FY2020 |
| 062-2020-2021-Q4-00143 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Regional Relief and Recovery Fund (RRRF) – Direct | $434,000 | FY2020 |
| 172-2018-2019-Q2-911900 | National Research Council Canada | Conseil national de recherches Canada · Canadian International Innovation Program | $210,000 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q1-947650 · retrieved 2026-11-13.